Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Clarient logo — Providing clarity in cancer diagnostics with community-focus...

Clarient

Providing clarity in cancer diagnostics with community-focused care and insightful therapy guidance.

Founded 1993 1001-5000 employees Venture round Total: $50.91M Biotechnology, Health Care

General Information

Company Name Clarient
Founded Year 1993
Employees 1001-5000
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Clarient. To contact Clarient, visit clarientinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Clarient compare?

A PDF of Clarient and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Clarient soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Clarient

Clarient is a leading player in the field of cancer diagnostic testing, founded in 1993. The company's commitment to providing clarity in cancer diagnostics is encapsulated in its slogan, "Providing clarity in cancer diagnostics with community-focused care and insightful therapy guidance." By collaborating closely with local pathologists and oncologists, Clarient ensures high standards of care within the community. Their comprehensive approach includes the utilization of various technologies to assist in diagnosing cancer, offering insights into the most effective therapies for patients, and providing ongoing follow-up and case monitoring. The last recorded investment for Clarient was a substantial $10.91M Venture Round in December 2009. This reflects investor confidence in the company's vision and capabilities. As a biotechnology and healthcare player, Clarient is poised to make a significant impact in the continued fight against cancer.

Business keywords: Cancer diagnostics, Community-focused care, Therapy guidance, Diagnostic testing, Collaboration with local pathologists, High standards of care, Technological solutions, Therapy insights, Follow-up and monitoring, Cytogenetics, Flow cytometry, FISH, Molecular genetics, Immunohistochemistry, Next-Gen Sequencing

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $10.91M -
31 Dec 2009
Venture Round $40.00M 1
Oak Investment Partners
Oak Investment Partners
19 May 2009

Clarient Alternatives & Competitors

Clarient vs
NeoGenomics Laboratories
NeoGenomics Laboratories United States

Answers are in our DNA™

IPO
1770 employees
Biotechnology, Health Care
Compare Clarient vs NeoGenomics Laboratories

FAQ About Clarient

Providing clarity in cancer diagnostics with community-focused care and insightful therapy guidance.
Clarient was founded in 1993.
Clarient operates in Biotechnology and Health Care. Its work centres on Cancer diagnostics, Community-focused care, Therapy guidance and Diagnostic testing.
Clarient has approximately 1001-5000 employees.
Clarient has completed 2 funding rounds, raising a total of $50.91M. The latest funding stage is Venture round.
Top alternatives and competitors to Clarient include NeoGenomics Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Clarient and NeoGenomics Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Clarient, https://bouncewatch.com/company/clarient, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes